• 146. Back to Basics - BRCA mutation and Breast Cancer Management

  • Feb 22 2025
  • Length: 25 mins
  • Podcast

146. Back to Basics - BRCA mutation and Breast Cancer Management

  • Summary

  • It's been an "Olympic" ride to get here, and this is our penultimate breast cancer episode! Today, we talk about the BRCA mutations and how they impact both breast cancer and outcomes using targeted therapy. BRCA is a tumour suppressor gene.


    Today, we explore olaparib and its role in the adjuvant and metastatic setting for breast cancer.


    Studies discussed in the episode:

    OLYMPIA

    OLYMPIAD


    For more episodes, resources and blog posts, visit www.inquisitiveonc.com

    Please find us on Twitter @InquisitiveOnc!

    If you want us to look at a specific trial or subject, email us at inquisitiveonc@gmail.com


    Art courtesy of Taryn Silver

    Music courtesy of AlisiaBeats: https://pixabay.com/users/alisiabeats-39461785/


    Disclaimer: This podcast is for educational purposes only. If you are unwell, seek medical advice.


    Oncology for the Inquisitive Mind is recorded with the support of education grants from our foundation partners Pfizer, Gilead Pharmaceuticals and Merck Pharmaceuticals. Our partners have no editorial rights or early previews, and they have access to the episode at the same time you do.





    Hosted on Acast. See acast.com/privacy for more information.

    Show More Show Less

What listeners say about 146. Back to Basics - BRCA mutation and Breast Cancer Management

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.